Embed Size (px)
Citation preview
1
Bruno MOURENZAHorizon 2020
Punto di Contatto Nazionale
SC1 e IMI-2
Strategic Initiatives around HEALTH
Innovative Medicines Initiative 2www.imi.europa.eu
European & Developing Countries Clinical Trials Partnership (EDCTP2)
www.edctp.orgActive and Assisted Living 2
www.aal-europe.eu
European Innovation Partnership on Active and Healthy Ageinghttps://webgate.ec.europa.eu/eipaha
Strategic Research Agenda
Antimicrobial resistance
Osteoarthritis
Cardiovascular diseases
Diabetes/Metabolic disorders
Neurodegenerative diseases
Psychiatric diseases
Respiratory diseases
Immune-mediated diseases
Ageing-associated diseases
Cancer
Rare/Orphan Diseases
Vaccines
The IMI portfolio
Private
Investment
in kind
(€ 1 billion)
EU Public
Funding
cash
(€ 1 billion)
EFPIA
ACADEMIA
HOSPITALS
PATIENTS’ORGANISATIONS
SMALL AND MEDIUM-SIZED ENTERPRISES
REGULATORS
Pharma
1
Pharma
2
Pharma
3
Pharma
4
Pharma
5
Pharma
6
A Typical IMI Consortium
Academic institutions
Small & medium-sized enterprises (SMEs)
Mid-sized enterprises (≤ €500m)
Non-profit organisations e.g. research organisations, patient organisations, NGOs, public bodies, intergovernmental organisations etc.
Established in:
EU Member States
Associated Countries
At least three legal entities
Who is eligible for funding?
Other countries: No funding unless - participation deemed essential by IMI for
carrying out the action- Annual Work Plan / Calls documents
New!
IMI partner search tool: https://cloud.imi.europa.eu/web/eimi-pst
IMI 2 – Call 18 Topics under considerations:Action Type: RIA – Research and Innovation Actions
• Central repository of digital pathology slides to support the development of artificial intelligence tools
• Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardized manner creating transparency of health outcomes
• Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project
• Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
• Accelerating research & innovation for advanced therapy medicinal products• Supporting the development of engineered T cells
Key dates and deadlines• Publication date: 26 June 2019• Stage 1 submission deadline: 26 September 2019 (17:00:00 Brussels time)• Stage 2 submission deadline: 26 March 2020 (17:00:00 Brussels time)• Project start: Autumn 2020
IMI 2 – Call 19 Topics under considerations:Action Type: RIA – Research and Innovation Actions
• Restricted Call to maximize impact of IMI2 JU objectives and scientific priorities
Restricted to the original consortia of actions funded under topics published in theIMI2 JU Annual Work Plan of 2014 and of 2015, since only these actions aresufficiently advanced in their implementation to be considered for follow-upactivities, and limited to those topics where the corresponding Work Plan alreadypre-informed potential applicants about the possibility of a later restricted Call (listpublished here).
Applicant consortia will be competing for a maximum total EU contribution of20M€.
Key dates and deadlines•Publication date: 26 June 2019•Submission deadline: 26 September 2019 (17:00:00 Brussels time)• Project start: Spring 2020
Participation of SMEs, patient groups, regulators, non-pharma sectors
It’s encouraged the participation of a wide range of health research and drug development stakeholders in our projects.
SMEs and mid-sized companies
Patient organisations
Regulatory bodies
Companies / organisations from related fields (e.g. diagnostics, animal health, IT, imaging etc…)
IMI2 - Call 18 & 19 webinars:
https://www.imi.europa.eu/news-events/events/imi2-call-18-19-webinars
Check potential future topics:https://www.imi.europa.eu/apply-funding/future-topics
Interested in applying?Read our tips for applicants and advice on finding project partners
Submit your ideas for new call Topics!This page introduces the process through which our Call topics are generated andexplains how you can submit ideas for new Call topics. If you are interested insubmitting an idea for a new topic, we advise you to read this page before filling inthe idea submission form.
Stay in touch
Visit our website
www.imi.europa.eu
Sign up to our newsletter
bit.ly/IMInewsletter
Follow us on Twitter
@IMI_JU
Join our LinkedIn group
bit.ly/LinkedInIMI
E-mail us
Grazie per l’attenzione!
APREAgenzia per la Promozione della Ricerca Europea
via Cavour, 71 00184 - Roma
www.apre.itTel. (+39) 06-48939993Fax. (+39) 06-48902550
Bruno [email protected]
Health NCP
15
